Continuing fallout from the mephedrone ban


This is the text of an article that appeared in the magazine “House” published for the House of Commons in London ( ).

In the pre-election ferment, one of the last actions of the outgoing government was to ban the “legal high” drug, mephedrone.  This occurred in a climate of rabid press calls for regulation, partly fuelled by the deaths of two young men from Scunthorpe, supposed to have taken the drug.  It now turns out that this evidence was incorrect, they had not taken mephedrone.  Nevertheless, given the febrile atmosphere, the ban may have given some people the comfortable feeling that a situation was under control.  

I doubt, however, that the situation is under control.  There was stockpiling of mephedrone before it was banned and some of that will now be circulating.  Some users will have switched back to cocaine or ecstasy of dubious purity.  Drug availability has, however, been changed forever by the provision of cheap synthesis in the Far East coupled with internet supply.  At the time of the ban there was speculation that other “legal highs”, provided via the ingenuity of chemists in the Far East, were already waiting in the wings to replace mephedrone.   We can now see some of these advertised by internet suppliers and all you need is a credit card to place an order. Naphyrone was one of these and it has very recently been recommended that this should become illegal.  Other examples of new drugs are MDAI, 5-IAI and 2-DPMP, all of which are currently legal; others are under development such as 6-APDB   So, banning mephedrone may have reduced its use but may have lead to switching to other, in some cases newer, drugs.

It is important to emphasise the uncertainty surrounding the use of these kinds of drugs.  Firstly, the psychological effects of the new drugs are not well established and there are some alarming reports circulating on the internet.  Secondly, we have only a rudimentary idea of how the new drugs, including mephedrone, work biologically and no idea how they affect the brains of young people upon prolonged use. The new drugs have often not been tested for toxic effects such as neurotoxicity, cardiotoxicity or causing cancer or birth defects.    Thirdly, for all of the drugs I have mentioned, there is the issue of their purity.  The suppliers on the internet claim high purity but there is no guarantee that the figures are accurate and samples obtained elsewhere may be cut with undefined substances.  A recent report showed that there was extensive mislabelling of these drugs.  Users may, therefore be consuming unknown mixtures of chemicals. 

People are, therefore, ingesting compounds of undefined biology, uncertain purity and unknown toxicity, acting unwittingly as human guinea pigs.    This unregulated situation is reminiscent of the mid 20th century era of pharmaceuticals.

Despite these potential dangers, people clearly want to take drugs to change their perception/mood.  We must try to understand this need and take action to protect people from the dangers. The government should urgently set up research programmes to study these new drugs. The research programmes should aim to understand how the drugs work as well as establishing their possible long term effects, including toxicity.  Once this information is available, the government should intensify public education programmes to make people aware of the risks they run when they take these drugs.

We should also consider one potential, but I believe unlikely, outcome of the research suggested above.  One or more of the substances mentioned above may turn out to be safe to use.  There would then need to be a debate about whether it might be better to supply these drugs in a regulated manner rather than allowing the present unregulated situation to prevail.


the known unknowns of mephedrone

The current debate in the UK about mephedrone is generating a lot of heat but not so much light.  Perhaps a look at the underlying science might point out some issues that have not been widely discussed. Let’s start at the end of 2009 when several “legal high” drugs were banned.

One of these was Spice, sold in head shops and on the internet and marketed as a herbal smoking mixture that promised a natural high.  Spice was very popular as a cannabis substitute and did indeed offer a high to those who smoked it.  It took some time before it was realised that Spice was not an innocuous herbal mixture.  It turned out that someone, probably in the Far East, was concocting a herbal mixture and then spraying this with some chemicals that had been shown to mimic the action of tetrahydrocannabinol (THC), the active principal of cannabis.  Two of the more popular chemicals used were JWH-018, originally synthesised in an academic lab in the US as part of a curiosity driven research programme and CP 47,497 originally synthesised by Pfizer as a potential drug but not developed.  Both of these compounds had been shown by their originators to mimic potently the actions of THC.  Other THC-mimics were also found in some batches of Spice and eventually the JWH-018 chemical itself became available over the internet. 

What do we learn from this?  Spice was not a uniform product and those who smoked it were consuming an unknown mixture of psychoactive chemicals.  Although the levels of these chemicals were not high, the levels were not defined, and neither was their purity.  Many of the chemicals had not been properly tested for toxic effects such as neurotoxicity or causing cancer or birth defects.  When JWH-018 became available it was also of uncertain purity and it’s availability meant that people could consume larger amounts leading to some frightening effects.  So the lessons from the Spice story are that people smoking Spice mixtures or taking JWH-018 were taking big risks as they didn’t know the composition or purity of the material and the potential toxic effects were undefined.

Let’s now move to 2010 and the recent controversy over mephedrone.  Mephedrone is a member of a class of chemicals called cathinones and has been available through head shops and the internet.  Cathinone was originally identified as the active compound in Khat, a plant preparation chewed as a stimulant  in Africa and the Arabian peninsula.  Mephedrone itself is not found in khat but is a synthetic cathinone.

We have a rudimentary idea about how some of the cathinones work; they have been shown to alter the brain levels of chemical messengers called neurotransmitters in a similar but not identical way to amphetamine or ecstasy.  The psychological effects of mephedrone reported by users are consistent with this.  Mephedrone has, however, been synthesised only recently and as a result there is no firm information on how it works or how it might affect brain function when consumed on a longer term basis.  We also have no idea about its potential toxic effects (neurotoxicity, cancer, birth defects etc).  As with JWH-018 there is the issue of the purity.  The suppliers of mephedrone on the internet claim high purity but there is no guarantee that the figures are accurate and samples obtained elsewhere may be cut with undefined substances.    

So in both the cases I have described, people are consuming chemicals of uncertain purity, unknown toxicity and, in the case of mephedrone, unknown biology.    We would not tolerate this situation in a pharmaceutical drug.  Indeed the unregulated situation with mephedrone is reminiscent of the mid 20th century era of pharmaceuticals.   I am also reminded of the story that emerged in 1982 when heroin addicts in California were sold a synthetic narcotic contaminated with an impurity called MPTP.   MPTP turned out to be a neurotoxin causing a syndrome very like Parkinson’s disease in users. 

Both Spice and mephedrone have now been banned but I doubt if this will contain the situation.  Demand for these kinds of drugs is not going to go away, and this will be satisfied by the internet and by synthesis of new compounds.  Chemical synthesis in the Far East is available readily and cheaply and there are reports that more chemicals have been prepared in time for the banning of mephedrone.  The ingenuity of these suppliers will ensure other chemicals enter our market.

What can be done?   The government should urgently set up a research programme on the biological and toxic effects of these new substances.  We would then know how the substances work and whether they do or do not pose risks.  We also need to understand why people want to take these drugs.  We could then use this knowledge about the drugs to educate people about the risks they may be running in taking them.




%d bloggers like this: